BIG PHARMA EARNINGS WATCH: MERCK, BRISTOL MYERS SQUIBB, NOVARTIS
Oct 28, 2022
New Earnings Reports Show Big Pharma Giants Basking in Massive Profits,… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA WATCH: DRUG MAKER PRICES CHEMO TREATMENT TEN TIMES ABOVE THE MARKET AS PATIENTS FACE SHORTAGES
Oct 28, 2022
Areva Pharmaceuticals Price-Gouges Cancer Patients Who Rely on Older Oncology… Read More
BIG PHARMA WATCH: BIG PHARMA’S EGREGIOUS PRICING PRACTICES FORCE MORE THAN ONE MILLION AMERICANS TO RATION INSULIN DUE TO COST
Oct 20, 2022
The Problem with Insulin Affordability is the Price, Driven by “Shadow… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 19, 2022
J&J Beats Q3 Earnings Expectations After Dozens of Prescription Drug Price… Read More
BIG PHARMA WATCH: BIG PHARMA HIKED PRICES FASTER THAN INFLATION ON MORE THAN 1,200 DRUGS FROM 2021-2022
Oct 4, 2022
HHS Reports Demonstrate Cost of Big Pharma Egregious Pricing Practices and… Read More
DOSE OF REALITY: NEW STUDY DEBUNKS BIG PHARMA CLAIMS THAT HIGH PRESCRIPTION DRUG PRICES ARE TIED TO R&D INVESTMENTS
Sep 29, 2022
JAMA Network Open Paper Finds “No Relationship” Between Drug Company’s… Read More
BIG PHARMA WATCH: BIOGEN TO PAY U.S. GOVERNMENT $900M FOR ANTI-COMPETITIVE KICKBACK SCHEME
Sep 27, 2022
Biogen Agrees to Settle Case Over Illegally Paying Doctors to Push Brand Name… Read More
BIG PHARMA WATCH: CEO UNDERCUTS OWN INDUSTRY’S DOOM AND GLOOM RHETORIC ON RECENT DRUG PRICING SOLUTIONS
Sep 22, 2022
Novartis Exec Calls Policy to Keep Price Hikes Below Inflation… Read More
DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR CANCER PATIENTS
Sep 20, 2022
Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology… Read More
BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”
Sep 15, 2022
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY
Sep 9, 2022
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC
Sep 1, 2022
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More